Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Mexico City design studio Locus has added skylights and solar panels to a circular holiday house in Mexico's Valle de Bravo to capture as much sunlight as possible. Casa Girasol is situated within ...

Most of the focus in generative AI has been on text-based interfaces used to generate text, images, and more. The next wave appears to be voice, and it’s rolling in fast. In the latest ...

We have two types of hair, says dermatologist Elizabeth Houshmand. Vellus hairs, or “peach fuzz,” cover virtually our entire body but aren’t easy to see. Our head, chest, armpit, and pubic hair ...

Adds Powerful, Breakthrough Innovations to LocusONE™ Platform Developed by LocusLABS to Drive High Performance, Efficiency, and Enterprise Scalability for Warehouse Fulfillment Operations ...

In 1923 episode 4, Taylor Sheridan wrote a scene in which the Dutton family ranch foreman, Zane (Brian Geraghty), undergoes dangerous surgery. A doctor determines that he has excess blood ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving one of the first rare treatments of its kind in Canada — a neurostimulation device ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...